Skip to main content
JR Holding SA logo

JR Holding SA — Investor Relations & Filings

Ticker · JRH ISIN · PLJRINV00013 LEI · 259400KSQ8PHW0768Y03 WAR Financial and insurance activities
Open in API
Filings indexed 754 across all filing types
Latest filing 2020-02-20 Director's Dealing
Country PL Poland
Listing WAR JRH

About JR Holding SA

https://jrh.ai/

JR Holding SA is an alternative investment company that invests in high-growth potential projects and businesses. The company's portfolio is diversified across future-oriented sectors, including AI and digital business, energy transformation, deeptech, the space industry, biotechnology, med-tech, and gaming. It also focuses on sustainability and the circular economy. JR Holding supports its portfolio companies by providing capital, strategic expertise, and access to an extensive business network, aiming to foster long-term value creation and achieve high rates of return on its investments.

Recent filings

Filing Released Lang Actions
Transakcje osoby mającej dostęp do informacji poufnych - Content (PL)
Director's Dealing Classification · 98% confidence The document text is very short (481 characters) and explicitly states that the company received a notification ('zawiadomienie') regarding the sale and purchase of shares by a Supervisory Board Member (Marek Sobieski) under Article 19(3) of the EU Market Abuse Regulation (MAR). Article 19 of MAR mandates reporting of transactions by persons discharging managerial responsibilities (PDMRs). This type of insider transaction reporting is specifically covered by the 'Director's Dealing' category (DIRS). Although the text mentions the content is attached as an annex, the primary nature of the announcement is the insider transaction itself, not just the announcement of a report's publication, making DIRS a more specific fit than RPA or RNS.
2020-02-20 Polish
Podpisanie Term Sheet dotyczącego wdrożenia terapii leczenia stwardnienia rozsianego - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the Management Board ('Zarząd') of JR HOLDING ASI S.A. It details the signing of a Term Sheet regarding a joint venture project focused on implementing stem cell therapy for multiple sclerosis. The text explicitly states that the company is providing this information because it will impact the issuer's financial results ('Spółka przekazuje niniejszą informację, ponieważ będzie ona miała wpływ na wyniki finansowe Emitenta'). This structure—a formal update on a significant business development that affects future financial performance, often referencing prior reports (ESPI nr 5/2020)—is characteristic of a mandatory regulatory disclosure concerning material events. Since it is not a full Annual Report (10-K), an Earnings Release (ER), or a specific financing document (CAP), and it details a major strategic business transaction (M&A/Partnership), it fits best under the general category for significant corporate events or regulatory filings. Given the context of Polish regulatory filings (ESPI reports), and the nature of the announcement detailing a major strategic investment/collaboration, it is a significant corporate event disclosure. It is not a specific financial statement, management discussion, or proxy material. It is most closely aligned with a general regulatory announcement or a material event disclosure that doesn't fit the other specific codes. Therefore, 'Regulatory Filings' (RNS) is the most appropriate fallback, although 'M&A Activity' (TAR) could be considered if the collaboration were framed as a merger, but this is a strategic partnership/investment. Given the lack of a specific code for 'Material Event Disclosure' outside of the defined list, RNS is the safest classification for a mandatory, non-standard disclosure.
2020-02-12 Polish
Podpisanie listu intencyjnego dotyczącego wdrożenia terapii leczenia stwardnienia rozsianego - Content (PL)
M&A Activity Classification · 95% confidence The document is a formal announcement from the Management Board ('Zarząd') of JR HOLDING ASI S.A. It details the signing of a tripartite letter of intent ('list intencyjny') regarding a joint venture for a biotechnology project involving patents and know-how related to a therapy for multiple sclerosis. The text explicitly states that this information will influence the issuer's financial results ('będzie miała wpływ na wyniki finansowe Emitenta'). This type of announcement, detailing a significant strategic investment, partnership, or potential acquisition/merger activity, aligns best with the Merger & Acquisition Activity (TAR) category, as it concerns a major strategic undertaking that could significantly alter the company's structure or future operations, even if it's currently framed as a letter of intent for a joint venture. It is not a standard earnings release (ER), interim report (IR), or a simple capital change (SHA). Given the nature of entering a major new venture involving patents and investment, TAR is the most appropriate fit among the strategic transaction codes.
2020-01-24 Polish
Zakup aktywów PREMIUM FUND S.A. przez Emitenta - Content (PL)
M&A Activity Classification · 92% confidence The document text, which is very short (772 characters), describes a transaction where the management (Zarząd) of JR HOLDING acquired a significant block of shares (21.36%) in another company (PREMIUM FUND S.A.) from the CEO (Prezesa Zarządu). This transaction involves the acquisition of shares, which falls under corporate activity related to investments or share ownership changes. Since it is a specific transaction involving the acquisition of a major stake, it is most closely related to M&A Activity (TAR) or potentially a Major Shareholding Notification (MRQ). Given the context of acquiring a 21.36% stake, this is a significant transaction that often precedes or is part of a larger strategic move, making 'TAR' (M&A Activity/Takeover Bids) a strong candidate, although 'MRQ' (Major Shareholding Notification) is also relevant for crossing ownership thresholds. However, the description focuses on the *acquisition* itself rather than just the notification of the resulting holding. In the absence of a specific 'Insider Trading' or 'Share Acquisition' code, and given the size of the stake, I will classify this as M&A Activity (TAR) as it represents a significant change in control/investment structure. If the document were purely a notification of crossing a threshold without detailing the transaction terms, MRQ would be better. Since it details the purchase price and intent, TAR is slightly more appropriate than MRQ or the general RNS.
2020-01-23 Polish
Zakup aktywów THUNDERBOLT S.A. przez Emitenta - Content (PL)
Director's Dealing Classification · 95% confidence The document describes a transaction where the management (Zarząd) of JR HOLDING acquired a significant block of shares (2,600,000 shares, representing 18.57%) in another company (THUNDERBOLT S.A.) from an executive (Prezes Zarządu). This action involves the acquisition of shares by an insider/related party, which falls under insider trading or director's dealing regulations, or potentially a major transaction. Given the options, 'Director's Dealing' (DIRS) is the most appropriate fit as it involves transactions by executives, although it is a transaction in shares of another entity. However, since the text explicitly details the purchase of shares by a director/executive, DIRS is the primary classification. If this were a transaction in the company's own shares, POS would apply, but here it is an acquisition of shares in a third party by an insider. DIRS covers personal share transactions by directors and executives.
2020-01-23 Polish
Zakup aktywów ALL IN! GAMES Sp. z o.o. przez Emitenta - Content (PL)
M&A Activity Classification · 85% confidence The document text describes a transaction where the Issuer (JR HOLDING) acquired shares in another company (ALL IN! GAMES Sp. z o.o.) from its CEO (January Ciszewski). This involves the acquisition of an equity stake, which falls under corporate transactions, specifically related to investments or capital structure changes. Since the transaction is an acquisition of shares/equity in another entity as part of an investment strategy, it is best classified as a Capital/Financing Update (CAP) or potentially a Regulatory Filing (RNS) if it were a mandatory disclosure not covered elsewhere. Given the context of acquiring an investment stake, CAP is the most specific fit among the provided options, although it is not a typical financing event like raising capital, it relates to the company's asset/capital structure. However, looking closely at the definitions, this is a report of a specific transaction/investment made by the company. Since there is no specific 'Investment Acquisition' code, and it is a report of a significant transaction, it is closest to Capital/Financing Update (CAP) or a general Regulatory Filing (RNS). Given the nature of acquiring an asset (shares), CAP seems plausible, but it is fundamentally a report of a transaction. If this were an insider trade, it would be DIRS, but this is the company itself making the acquisition. I will classify this as a general Regulatory Filing (RNS) as it reports a specific corporate action that doesn't fit perfectly into the other transactional categories like M&A (TAR) or Share Issue (SHA).
2020-01-21 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.